Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Click here to unsubscribe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• IVB injections
• Iluvien's German approval
• Glaucoma damage detection
• OBL astigmatism
 
 
Survey

Would you consider using a combination of corticosteroids and plasma exchange for optic neuritis?

Yes
67%
No
33%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
August 15, 2012
IVB injections successful for mCNV
Intravitreal bevacizumab (IVB) provide sustained and effective treatment for myopic choroidal neovascularization (mCNV). More...
DME treatment gets the German green light
Chronic diabetic macula oedema (DME) treatment Iluvien, developed by Alimera Sciences, has obtained marketing authorization in Germany. More...
City Guide
Continuing Ophthalmology Times Europe's series of City Guides, Seeing Milan, sponsored by Oertli, will help you get the most out of your stay. To read more please click here
Glaucomatous damage detected with SD-OCT
SD-OCT imaging and retinal nerve fibre layer (RNFL) assessment successfully detects pre-perimetric glaucomatous damage. More...
OBL astigmatism could require additional correction
Correcting pre-existing astigmatism could be necessary for achieving excellent visual outcomes in eyes with oblique (OBL) astigmatism. More...